Wednesday, November 5, 2014

PARENTERAL DRUGS ADMINISTRATION

This is the most suitable route of administration of drugs in treating patients who are non-cooperative, unconscious or are otherwise unable to take the medicine orally.   

DISADVANTAGES OF PARENTERAL PRODUCTS:

  • It is expensive.
  • People may have fear about the injectable syringes.
  • These products must be maintained strictly t keep them sterile.
  • Specialized equipment as well as trained persons is needed for their administration.
  • These may be painful after administration.
  • Application through wrong routs may prove fats.
  • Daily or frequent administration of injections may pose difficulties to the patient.


Intra-cutaneous or Intra-dermal Injections:

These injections are given in between dermis and epidermis. Skin of the left forearm is usually selected for giving the injection.
Usually small volume, from 0.1 to 0.2 ml can be injected by this route.
Mainly used for testing the sensitivity of the injectables and for diagnostic purposes.

Sub-cutaneous or Hypodermic Injections:

These injections are given in the sub-cutaneous tissue under the skin of the upper arm. Normally vaccine is injected into this route.
The volume of 1 ml or less can be injected by this route.
Aqueous suspensions and Oily suspensions & fluids cannot be injected by this route
Most popular route because it is convenient for the patient and the doctor.

Intra-muscular Injections:

These injections are given into the muscular tissues of the shoulder, thigh or buttock.
Generally volume up to 2 ml is administered by this route and should not exceed 5 ml at one site. Specially 5 ml for gluteal region and 2ml for deltoid region are referred. 

Intravenous Injections:

Large volume of solutions ranging from 1 to 500 ml or even more can be injected but volumes of more than 1.5 ml should be isotonic with blood.
These injections are given into the vein therefore directly reach the blood stream. The median basilic vein is usually selected because it is easily located and connects with the other major veins of the arm.
Oily injections and suspensions cannot be injected by this route.  

Intra-arterial Injections:

These injections are given directly into the artery for an immediate effect in a peripheral area. But they are occasionally used. (eg. Tolazoline hydrochloride.) 
Generally 10 ml can be injected by this route. 
Intra-cardiac Injections:

They are given directly into the heart muscles or ventricle. (eg. Adrenaline or isoprenaline sulphate.)
This route is used in emergency only.

Intrathecal Injections:

They are given into the subarachnoid space surrounding the spinal cord.
This route is used for giving spinal anaesthesia (Bupivacaine) and antibiotics (streptomycin in the treatment of tubercular meningitis.)

Intracisternal Injections:

They are given in between the first and second cervical vertebrae.
This route is principally used to withdraw cerebrospinal fluid for diagnostic purposes and occasionally used for antibiotic treatment.

Peridural Injections:

These injections are given between the duramater and the inner aspects of the vertebra.
This route is sometimes used for giving spinal anesthetics in special cases.

Intra-articular Injections: These injections are given into the synovial fluid that lubricates the articulating ends of bones in a joint.

Intracerebral Injections: These injections are given into the cerebrum.
OFFICIAL TYPES OF INJECTIONS:

Parenteral preparations are classified by the USP and NF according to the following five classifications:

Solutions, suspension or emulsion of medicaments suitable for injection, referred to by titles of the form “-------------- injection”.
Example: Insulin injection, USP. Morphine injection USP.

Dry solids or liquid concentrates containing no buffers, dilutes or other added substances and which upon the addition of suitable solvents yields solutions conforming in all respects to the requirements for injections and which are distinguished by titles of the form “sterile-------------”.
Example: Sterile Chloramphenicol Sodium Succinate, USP. Sterile Ampicillin Sodium, USP.

Again the above type of preparations when contains one or more buffers, diluents or other added substances it is defined by title of the form “----------------- for injection.”
Example: Sodium Thiopental for injection, USP. Methicillin Sodium for injection, USP.

Solids which are suspended in a suitable fluid medium and which are not to be injected intravenously or into the spinal canal distinguished by the title of the form “sterile ------------- suspensions”.
Example: Sterile Cortisol Suspension, USP. Sterile Epinephrine Suspension, USP.

Dry solids which upon the addition of suitable vehicles yields preparations conforming in all respects to the requirements for sterile suspensions, which are distinguished by titles of the form, “sterile ----------- for suspensions.”
Example: Sterile Chloramphenicol for Suspension, USP. Sterile Ampicillin for Suspension, USP.

Emulsions of fluids in fluid media, suitable for parenteral administration, which are not to be injected into the spinal canal and which are distinguished by titles of the form “sterile ------------------ emulsions.”
Example: Sterile Phytonadione Emulsions, USP.        

DIFFERENCE BETWEEN THE INJECTIONS AND ORAL PREPARATIONS:

The solutions and suspensions of drugs intended for injection are prepared in the same general manner as for oral solutions and suspensions with the following differences:

Solvents or vehicles used must meet special purity and other standards assuring their safety by injection.
The added substances like buffers, stabilizers and antimicrobial preservatives should fulfill the specific guidelines of use and restricted in certain parenteral preparations.
The use of coloring agents is strictly prohibited.
Parenteral preparations are always sterilized & meet sterility standards and must be pyrogens free.
Parenteral solutions must meet compendial standards for particular matter.
Parenteral products must be prepared in environmentally controlled areas, under strict sanitation standards.
Parenteral products must be prepared by specially trained personnel and clothed to maintain the sanitation standards.
Parenteral products are packaged in special hermetic containers of specific and high quality.
Each container of an injection is filled to a volume in slight excess of the labeled “size” or volume to be withdrawn.
There are restrictions over the volume of injection permitted in multiple-dose containers and also a limitation over the types of containers which may be used for certain injections.
Specific labeling regulations apply to injections.
Sterile powders intended for solution or suspension immediately prior to injection is frequently packaged as lyophilized or freeze-dried. Powders to permit ease of solution or suspension upon the addition of the solvent or vehicles.        
The following factors must be considered for the preparation of parenteral products:

Volume of injection.
Stabilizer.

Adjustment of PH.
Preservatives.

Adjustment of specific gravity.
Adjustment of isotonicity. 
Vehicles.


Volume of injection:

The volume of injection primarily depends on: ---

The solubility of the medicaments.
The particular route of administration. (eg. Intracutaneous injection have to be small other than IV route is suitable for large volume.)

The volume should be convenient to administer, like: volume greater than 20ml is unsuitable for injection by a syringe. For dispensing a hypertonic solution, the volume can often be reduced and administered by slow IV infusion.

Adjustment of PH:

The PH of many official preparations is adjusted to a definite PH or to within a PH range. The PH of a completed injection can be altered by: -------

The decomposition of the medicament.
Leaching of alkali from the glass container.
Extraction of acid or alkaline impurities from the rubber closure.
Dissolving of gases and vapors from the airspace in the container.
Thus adjustment of PH is very necessary for parenteral preparation. Some of the reasons for PH adjustment are as follows:

To increase the stability of the injection: The optimal stability may prove a suitable formulation. As unfavorable PH is one of the major causes of instability in pharmaceuticals preparations. Thus adjustment of PH to the optimum plays a vital role for maximum stability.

Eg.
PH

Alkaloids (Ergometrine injections)
2.7-3.5

Vitamin (Cyanocobalamin)
Polypeptides (Oxytocin) 
4.0-5.5
3.0-4.5


To minimize pain, irritation and necrosis: Since for subcutaneous and IM routes, very acid or alkaline solutions are painful on injection and may cause irritation or even necrosis of the tissue. On the other hand, non-neutral solutions can cause aseptic meningitis in Intrathecal, Peridural and Intracisternal routes. Thus adjustment of PH between the ranges of 7.0-7.6, ideally PH 7.4 should be maintained.

To provide unsatisfactory conditions for growth of micro-organisms: Use of low and high PH prevents the growth of micro-organisms. Solutions of PH below 4 are bactericidal for many micro-organism and many not require additional protection against bacteria. Example: Ethanolamine Injection does not contain any bactericidal in multiple-dose containers for its anti-bacterial activities due to its high PH of 8-9.

To enhance physiological activity: Maximum physiological activity is shown by neutral or alkaline solution if maximum stability is found in acidic PH. Thus PH should be kept as high as physiologically possible with an acceptance level of stability. Generally, in most cases, the biologic effectiveness of the drug is maximum at or near the biologic fluid PH rather than at the stabilizing PH of the injected products. Example: Procaine and Adrenaline solution produce the greatest anaesthetic effect than its salts.

To help detect decomposition: Decomposition of a medicament in solution is often accompanied by a PH change. Thus PH change can be used to detect deterioration when physical observation in storage condition, according to pharmacopoeia, is failed such as protection from light and refrigeration.

Buffers: Buffers systems are added to maintain a required PH for many products. Buffers systems must be selected with consideration of their: ------
Effective range.
Concentration and
Chemical effect on the total product.

Buffers systems suitable for injections: -----
Should have no toxicity.
Be compatible with the medicaments.
Be compatible with the excipients.
Should have a high buffer capacity.

Example:
Citric acid/Na-phosphate (Digixin Injection B.P)
Na-acetate (Insulin Zinc suspension Injection B.P)
Na-phosphate (Isophane Insulin Injection B.P)

Adjustment of specific gravity:

For injection, the specific gravity of the solution must be made carefully. Adjustment of specific gravity plays a vital role in spinal anaesthesia. The specific gravity of solution in relation to that of the C.S.F is isobaric, hypobaric and hyperbaric i.e. of equal, lower and higher specific gravity respectly. Example: Cinchocaine HCl 1 in 1500 in 0.5% saline is hypobaric and cinchocaine HCl 1 in 200 in 6% dextrose is a hyperbaric solution.

Adjustment of isotonicity:

Tonicity refers to the tone of a solution and is directly related to the osmotic pressure exerted by the solution. Isotonic solution exerts the same osmotic pressure as blood or 0.9% NaCl solution. Hypertonics have a greater osmotic pressure than blood or 0.9% NaCl solutions. Hypotonic solutions have a lower osmotic pressure than blood or 0.9% NaCl solution. Isotonicity actually depends on the permeability of a living semi-permeable membrane that separates the solution from a biologic cell system.

For Intravenous Injections: Approximate isotonicity is always desirable. All hypotonic solutions should be rendered isotonic, because administration may lead to pain and hemolysis due to expand the cell. Hypertonic solutions are administered through a central rather than peripheral vein to avoid pain caused by RBC shrinkage. For diagnostic purpose, hypertonic solution is used for sclerosing varicose veins. Example: Morrhuate Na Injection U.S.P, Ethanolamine Oleate Injection B.P. 

For Subcutaneous Injections: The injection volume is very small and injected directly into fatty tissue. So isotonicity is desirable but no essential. Other hand a wide range of Para-tonicity is possible without unwanted effects.

For Intramuscular Injections: The osmotic pressure will vary according to the type of Injection and its desired therapeutic use. Aqueous solution should be slightly hypertonic to promote rapid absorption. Aqueous depot formulation should be isotonic. A hypertonic vehicle might hasten absorption. 

For Intracutaneous Injections: Intracutaneous route is used for diagnostic purposes. And the diagnosis is dependent on the subsequent development of an immune response involving inflammation. Thus diagnostic preparation should be isotonic since a paratonic solution might cause a false reaction.

For Intrathecal Injections: These must be isotonic. The volume of C.S.F is only 60-80ml. Hence a small paratonic solution will disturb the osmotic pressure and may cause vomiting and other effects.     

Example:
Compound

Concentration range (%)

Mannitol
0.4 – 2.5  

Dextrose
3.75 – 5.0

NaCl
Varies

Na-sulfate
1.1

Sorbitol
2.0


Stabilizer:

To maintain the require stability, parenteral preparation must fulfill the following requirements: --------

Adjust of PH: Adjustment of PH is a major method of stabilizing injection because decomposition is often catalyzed by hydrogen (H+) or hydroxyl (OH-) ions.

Addition of reducing agents or antioxidants: Addition of reducing agents or antioxidants prevents the oxidation of the products by the following ways:

By being preferentially oxidized and thereby gradually used up.
By blocking an oxidative chain reaction in which they are not usually consumed.
In addition, certain compound known as effectiveness of antioxidants, particularly those blocking oxidative reaction. On the other hand some chelating agents are used in this connection in that they complex with catalysts that otherwise would accelerate the oxidative reaction.    

            There are four types of antioxidants:


Example:
Compound

Concentration range (%)

 Antioxidants (reducing agents)


Ascorbic acid
0.02 – 0.1

Na – bisulfite
0.1 – 0.15

Na – metasulfite
0.1 – 0.15


Antioxidants (blocking agents)


Ascorbic acid esters
0.01 – 0.015

BHT
0.005 – 0.02

Tocopherols
0.05 – 0.075


Synergists


Ascorbic acid
0.01 – 0.05

Citric acid
0.005 – 0.01

Tartaric acid
0.01 – 0.02


Chelating agents


EDTA salts
0.01 – 0.075


Replacements of air by an inert gas: Presence of oxygen is a serious cause of decomposition. Thus to improve stability, oxygen must be replaced by an inert gas from the final container. Eg. Influx of N2 in ergot alkaloid containing injection.

Use of sequestering agents: Trace qualities of many heavy metal ions often catalyze destructive changes in medicaments. Such as Cu, Pb, Hg and Zn break the S-containing ring of penicillin-G. Cu, Fe and Cr cause oxidation of adrenaline. These effects can often be prevented by adding a substance called sequestering agents that will form a water soluble co-ordination compound with metal and cease ionization. 

Example:
Ethylenediaminetetra acetic acid (EDTA)


Dimercaprol


Na-polymetaphosphate

Preservatives:

Preservatives or antibacterial agents must be present in multi-dose containers. They must be added in adequate quantities to prevent the multiplication of micro-organism which may be accidentally introduces into the preparation while withdrawing a dose from the multi-dose containers.
The desirable features of a suitable preservative for multi-dose injections were summarized as: ------

Should be able to prevent the growth of and preferably to kill contaminating organisms.
Should be compatible with the medicament, even on long storage.
Should not interfere with the therapeutic efficacy of the product.
Should have low absorption rate into rubber.
Should be non toxic to the patient.
Should have a broad spectrum of activity to include fungi as well as vegetative bacteria.
Should be active over a wide PH range.
Should be uninfluenced by the container.
Should be stable in aqueous solution at high temperatures if the injection is to be sterilized by moist heat process.

Limitations: Bactericidal agents cannot be used in Infusion fluids. Also it should not be used in Intra-cardiac, Intra-arterial, Intrathecal, Intracisternal and Peridural Injections. 

Eg.            
Compound

Concentration range (%)

Benzyl alcohol
0.5 – 10.0

Butylparaben
0.015

Metacresol
0.1 – 0.25

Methylparaben
0.01 – 0.18

Phenol
0.065 – 0.5

Phenylmercuric nitrate
0.001

Propylparaben
0.005 – 0.035

VEHICLE:

For the preparation of parenteral products one will have to use a suitable vehicle for dissolving or suspending the medicaments. The vehicle used for the parenteral preparations must have the following criteria: --------

Should be pharmacologically inert.
Should be pure and non-toxic (compatible with blood, non-sensitizing and non-irritating.).
Should maintain the solubility of the drug.
Should be chemically and physically stable.
Should be unaffected by PH change.
Should not interfere with the therapeutic activity of the medicaments.

Vehicles used for parenteral preparation can be divided into two main types: --------

Aqueous 
Non – aqueous


Aqueous solvents: The vehicle used in parenteral products has the first preference for the aqueous solvents i.e. water because:--
Aqueous preparations are tolerated well by the body.
They are safest and easier to administer.
It is more available and cheapest.
The following aqueous vehicles are used for the preparations of parenteral products: -----

Water for Injections U.S.P:

This water is purified by distillation or by reverse osmosis or diamination.
It is well tolerated by the body and ionizable electrolytes readily dissolve in water.
It is not required to be sterile but must be pyrogens free.
It must also have a high level of chemical purity.
It meets the total solid content of not more than 1mg/100ml and may not contain added substances.
It should be freshly boiled, cooled and stored in a well closed container to avoid reabsorption of O2 and CO2.
It should be stored in tight container at temperature below and above the range in which microbial growth occurs.
It is intended to be used within 24 hours following its collections.

Sterile Water for Injections U.S.P:

This water has been sterilized and packaged in single-dose containers of not more than 1 liter size.
It must be pyrogens free and may not contain anti-microbial agents.
It may contain a slightly greater amount of solid than water for Injections.
It is intended to be used as a solvent, vehicle or diluents for already sterilized and packaged injectable medication.

Bacteriostatic Water for Injections U.S.P:

This water is sterilized water for injection containing one or more suitable anti-microbial agents.
It is packaged in vials containing not more than 30ml of the water.
The container label must state the name and proportion of the anti-microbial agent present.
It is employed as a sterile vehicle in the preparation of small volumes of injectables preparations. (Because large amount of anti-microbial agent is harmful for the body.)

Sodium Chloride (NaCl) Injections U.S.P:

It is sterile and isotonic solution of NaCl in water for injections.
It contains no anti-microbial agent and the content of Na+ and Cl- ion is about
154 mEq of each per liter.
It is used as a sterile vehicle in preparing solutions or suspensions of drugs for parenteral administration. 

Bacteriostatic Sodium Chloride (NaCl) Injections U.S.P:

It is sterile and isotonic solution of NaCl in water for injections.
It contains one or more anti-microbial agent which must be specified on the labeling.
It may not be packaged in containers greater than 30ml in size.
Ringer’s Injections U.S.P:

It is a sterile solution of NaCl, KCl and CaCl in water for injections.
These agents are present in concentrations similar to physiological fluid.
It is employed as a vehicle for other drugs, of alone as an electrolyte replenisher and fluid extender.

Non – Aqueous solvents: Oily vehicles are used when the use of water in contraindicated in one way or the other eg. -------
When the medicament is insoluble or slightly soluble in water.
To increase the stability of the preparation.
To prolong the duration of action of a drug.

Criteria of non-aqueous vehicles:

Should be nontoxic, non-irritating and non-sensitizing.
Must not adversely affect the active ingredients.
Should not exert pharmacologic activity of its own.
Must be administered intramuscularly.
The physical and chemical properties of the solvents would be suitable for the task at hand before they are employed.
Must maintain its fluidity over a wide temperature range.
Should have high boiling point to permit heat sterilization.
Should have proper miscibility with body fluids and lower vapour pressure to avoid problems during heat sterilization.

Disadvantages of non-aqueous vehicles:

They may be too viscous in cold weather to administer without warming.
They often cause pain at the site of the injections.
They will contaminate the syringe and needle making them difficult to clean.
They must be used only by the intramuscular route, since their accidental intravenous injection may lead to thrombosis.

Types of non-aqueous vehicles: The following non-aqueous vehicles are used for the preparation of parenteral products:

Water miscible vehicles: Dioxalanes, Dimethyl acetamide, Polyethylene glycol, Propylene glycol, Glycerin and ethanol etc.

Water immiscible vehicles: Fixed oils (vegetable origin) eg. Corn oil, Cottonseed oil, Peanut oil, Olive oil, Sesame oil, ethyl oleate, isopropyl myristate and Dimethylacetamide etc. 

 

WATER FOR INJECTIONS U.S.P:

Water for injections is the most extensively used vehicle in parenteral preparations. This water is purified by distillation or by reverse osmosis or diamination process. It occurs as a clear, colorless and odorless liquid. It has the following specific criteria than other liquids or waters: ------

It is well tolerated by the body and ionizable electrolytes readily dissolve in water.
It is not required to be sterile but must be pyrogens free with less than 0.25 endotoxin units per ml.
It must also have a high level of chemical purity.
It meets the total solid content of not more than 1mg/100ml and may not contain added substances.
It should be freshly boiled, cooled and stored in a well closed container to avoid reabsorption of O2 and CO2.
It should be stored in tight container at temperature below 40C and above 370C, the range in which microbial growth occurs.
It is intended to be used within 24 hours following its collections.

Preparation of water for injections:

Apparatus: The usual method of preparing water for injections is distillation. In distillation process, metal still is suitable for preparing water for injections. In general, the conventional still is composed of:

A boiler or evaporator containing feed water or distilland.
A heater (source of heat to vaporize the water.)
A headspace with condensing surface known as baffles (for returning non-volatile impurities to the distilland or water.)
A condenser (removes the heat of vaporization and converts the water vapour to a liquid.)

Procedures: The following procedure is followed for the preparation of water for injections:----

The source of water used in the preparation of water for injections by distillation may be contaminated with suspended mineral & organic substances, mineral salts and chemicals. Thus to improve the quality of the end product the source water may be pretreated by: ----

Chemical softening
Filtration
Deionization
PH adjustment
Carbon adsorption

Then the feed water is heated in the evaporator for boiling.
The vapor produced in the tubes is separated from the entrained distilland in the separator and conveyed to a compressor.
Within compressor, the vapor is compressed and raised its temperature to approx. 1070C.
It then flows to the steam chest where it condensed on the outer surfaces of the tubes containing the distilland.
The vapor is thus condensed and drawn off as a distillate.  

Collections and tests: In operation, the first portion of the distillate must be discarded. The remainder is collected in a suitable storage vessel. The chemically quality of the freshly collected distillate should comply with the limit tests for purified water. However, it will typically have the following additional quality limits:

Chlorides
Less than 0.5 p.p.m.

Ammonia
0.1 p.p.m.

Heavy metals
0.1 p.p.m.

Oxidizable substances
Less than 5 p.p.m.

Residues on evaporation
Less than 0.001%

PH
5.0 – 7.0


Storage: Care is required in handling the freshly collected distillate as it is subject to microbial contamination during storage and distribution. Two systems are commonly used for the storage of water for injections: -------

Batch storage 
Dynamic storage


CONTAINERS:

Container is a vital factor for the preparation especially of parenteral products because, these are in intimate contact with the product, the desirable properties for containers of injections is as follows: -----

The containers should maintain the sterility of the packed fluids and also be compatible with the packed fluids.
There should be no surface changes of the container at the temperature and pressures associated with sterilization.
They should protect photosensitive contents from the light.
In hospital practice, for economic reasons, it should either be cheap enough to dispose of after one use or be easy to clean and reuse.
The contents should be easy to examine through the containers to detect particles, contamination and decomposition.
They must be non reactive, non toxic and not to impart to the product taster or odors. 
They must be adaptable to commonly employed high-speed packaging equipment.



Generally the following two types of materials are used to prepare containers for packaging the parenteral preparation: ------

Plastic containers  
Glass containers


Plastic containers:

Plastics are synthetic polymers of high molecular weight. Plastics are in regular use for packaging certain types of sterile products including infusion and dialysis fluids.

General properties:

They are sensitive to heat and may melt or soften at below 1000C.
They are light in weight. So easier to handle and cheaper to transport.
Mechanically they are almost as strong as metals.
They are poor conductors of heat.
Generally they are resistant to inorganic chemicals but often attacked by organic substances. (solvents and oils)
Very few types completely prevent the entry of water vapour at all the temperature to which an injections containers may be exposed.

Advantages:

They are cheap materials and easy to mould.
They are flexible and not easily broken.
They are of low density and thus light in weight.
They can be heat sealed.
They are suitable for use as containers, closures and as secondary packaging. 

Disadvantages:

They are not as chemically inert as glass.
Some plastics are very heat sensitive.
Some plastics undergo stress cracking and distortion on contacting some chemicals.
They are not as impermeable to gas and vapour as glass.
They may possess an electrostatic charge which will attract particles.
Additives in the plastic are easily leached into the product.


Generally the plastic used to pack injections are thermoplastic in nature. These soften on heating to a viscous fluid and harden on cooling. Those uses include: -------

Polyethylene (polythene)  
High-density polythene

Polyvinyl chloride (P.V.C)
Polystyrene

Polypropylene
Polytetrafluoroethylene (Teflon)

Polyamides (nylon)
Polycarbonate

Polyethylene (polythene):

Advantages:

It is flexible, very light but tough plastic that is practically impermeable to water vapour.
Pure polythene frees from plasticizers and others adjuncts.
It is non toxic to human tissues even when implanted for long periods.

Disadvantages:

It has relatively high permeability to gases cause drug deterioration. (Penetration of O2 can lead to discoloration of tetracycline suspensions).
Certain oils and preservatives may penetrate through it.
It has lack of transparency.
It tends to charged with static electricity which attracts dust.
Sterilization is difficult because its melting point range is 1100C – 1150C and begins to soften at about 900C. 

Uses: It is widely used for bottles, tubing and heat sealable packaging films due to its water impermeability and ease of fabrications.

High – density polythene:

Advantages:

It is more rigid and consequently handling and filling of containers is easier and their walls can be thinner.
Its permeability to gas is low and resistance to oils high.
It can be sterilized by autoclaving due to its higher melting point.

Uses: It is used for disposable syringes and the packaging of infusion fluids. 

Polyvinyl chloride (P.V.C):

Advantages:

It has high clarity.
It is practically unaffected by sunlight.
Its un-plasticized materials are non toxic.
It is less permeable to gases than polythene.
Its plasticized grades are good oil resistant.
Some grades can be sterilized by autoclaving.
The surface can be printed readily.   

Disadvantages:

It is less flexible, heavier and much more permeable to water vapour.
It adsorbs some drugs.
It require an extended sterilization time due to its heat resistance.
For most heat sterilization requires air ballasting to avoid pouch explosion.

Uses: P.V.C collapsible bags are used to package most infusion fluids.  
Polystyrene:

Advantages:

It is light & cheap materials and easy to mould.
It is odorless, tasteless and available in transparent.
It has excellent dimensional stability that assure to fine limits of accuracy.
It softens at a lower temperature than other plastics.

Disadvantages:

It is hard and rigid materials.
It is brittle to cold.
It permits the permeability of water vapour than others plastics.
It tends to be electrostatic and very permeable to aromatics flavourings.

Polypropylene:

Advantages:

It is the lightest known plastics.
It has greater heat resistance.
It has very high resistance to repeated flexing.
It can be autoclaved repeatedly. 

Uses: It is used for disposable syringes. It is the best plastic to date for dialysis fluids and irrigations.

Polytetrafluoroethylene (Teflon):

Advantages:

It has excellent heat resistance.
It resists all known solvents and chemicals except gaseous fluorine.
Its water absorptions are nil.
Its moisture vapour permeability is less than that of polythene.   

Disadvantages:

It is very expensive and difficult to fabricate.

Polyamide:

Advantages:

It has excellent heat resistance.
It has good resistance to vegetable oils and many solvents and chemicals.
It can be autoclaved repeatedly at 1210C.   

Disadvantages:

It is not transparent.
Its water vapour permeability is relatively high.

Polycarbonate:

Advantages:

It has excellent dimensional stability.
It is transparent.
It has very good heat resistance.
Its water absorption is low.
It is not susceptible to oxidative degradation.  

Glass containers:

Glass is the first preferred materials of container for parenteral products. Glass is composed principally of the silicon-dioxide (SiO2) tetrahedron. It is physico-chemically modified by the treatment with such oxides as those of Na, K, Ca, Mg, Al, B and Fe.


The most chemically resistance glass is composed almost entirely of sodium dioxide (Na2O2) but it is relatively brittle and can only be melted and molded at high temperature. Boric oxide somewhat modified the above characteristics. 

Advantages:

Glasses are transparent and chemically inert.
They are impervious to air and moisture.
They are easy to clean and sterilized by heat.
They are strong.
They may be used for products which are incompatible with plastic containers.    

Disadvantages:

They are much heavier than plastic and less transportable.
They are brittle and subject to damage during transport and storage.
During use they require the use of an air inlet filter device for pressure equilibration within the container.
Particles of glass can be released into the injection fluids.
They are unsuitable for moist heat sterilization.
They are fragile and expensive than plastic.

On the basis of the results from the official test, glass compounds are classified into four types: --------

Types I glass   
Types II glass

Types III glass
NP glass

Types I glass (Borosilicate glass):

Compositions:

This is a borosilicate glass or pyrex glass. It is principally composed of silicon-dioxide (SiO
2) and boric oxide with low level of the non-network forming oxides. The approximate composition of the pyrex glass are as follows: --------

80% SiO2   
2% Al2O3

12% B2O3
6% Na2O + CaO + other oxides


Characteristics:

It is a chemically resistant glass (lowest leachability).
It has a low thermal co-efficient of expansion.
It is difficult to melt and mold.

Uses: Borosilicate glasses are used for chemical glassware, ovenware and containers for alkali sensitive preparation. Now a day, in our country, it is not widely used for injection containers although some antibiotic vials are made from it.

Types II glass (Treated soda-lime glass):

Compositions:

It is treated soda-lime glass. It is treated under controlled temperature (above 5000C) and humidity conditions with SO2 to dealkalize the surface of the container by producing a Na-sulfate (Na2SO4) layer. This process is known as “Sulphuring”. This surface is chemically more resistant but repeated sterilization and alkaline detergents will breakdown this dealkalized surface. 

Characteristics:

It is chemically less resistant and melts at a lower temperature.
It is easier to mold into various shapes.
It has a higher thermal co-efficient of expansion than type I.
Types II glass usually has a lower concentration of the migratory oxides than types III.

Uses: It is used for the containers of blood, Plasma and infusion fluids. It is also used for a solution which is buffered has a PH below 7 or is not reactive with the glass. Now a day, it is used in our country for dry salt penicillin vials.

Types III glass (Regular soda-lime glass):

Compositions:

It is regular soda-lime glass. It contains approximately: -------

75% SiO2   
10% CaO

15% Na2O
<1% Al2O3, MgO, K2O


The Al2O3 improves mechanical strength and chemical durability and makes melting easier. MgO reduces the manufacturing temperature of glass and widens the temperature range over which the glass can be shaped into containers.
Characteristics:

It is sufficiently resistant to the action of water for ordinary purpose.
It is unsuitable as a container materials for many injections because: ------
It yields an appreciable quantity of alkali to water.
Flakes separate comparatively easily.
On repeated use its surface loses some of its brilliance.
It’s relatively high co-efficient of expansion makes it liable to fracture with sudden changes of temperature.
Uses: It is used principally for anhydrous liquids or dry substances.

NP glass (Non parenteral glass):

This is a soda-lime glass (general glass) and composed of sodium oxide (Na2O) and calcium oxide (CaO). They are not suitable for parenteral solutions containers because it provide the least chemical resistance. So it is used for non-parenteral products such as tablets, capsules, oral solutions and suspensions etc.

CLOSURES:

Rubber consists of long chain polymers of isoprene units linked together in the cis-position. Hevea braziliensis is the most important source of rubber. Its latex contains 30% to 40% of rubber in colloidal suspension. Usually closures for parenteral products are made from -------
   
Natural rubber  
Synthetic rubber


Characteristics of good pharmaceutical rubber: A good pharmaceutically used rubber consists the following criteria:

Should show good ageing property.
Should have satisfactory hardness and elasticity.
Should have resistance to sterilization conditions.
Should not affect by moisture and air.
Should have low permeability to moisture and air.
Should have negligible release of undesirable substances.
Should have negligible extraction of injection ingredients.

Natural rubber:

Disadvantages: The chief disadvantages of raw rubber are: -----------

Its elasticity is poor.
Its strength is poor.
It’s hardens when cold and become soft and sticky when warm.
It dissolves in many solvents.

Thus a large number of substances are added to give better chemical and physical properties and facilitate manufacture. Such as: ------- ---------

A Vulcanizing agent: It improves its strength and reduces its susceptibility to temperature changes. Example: Sulpher.
Accelerators: It improves its strength and resistance to oxidation. Example: Thiazoles (2 mercaptobenzthiazole), Thiurams (tetramethyl thiuram disulphide).

Activators: It increases the activity of accelerators. Example: Stearic acid or Zinc stearate for M.B.T. and Zinc oxide for T.M.T.

Softeners: It influences the hardness of the finished products. Example: Pine oil, Mineral oil.

Fillers: Rein forcing fillers improves physical properties and extending fillers used as diluents to reduce its cost and partly to facilitate manufacture. Example: Carbon black, Talc, Whiting, Asbestos.

Antioxidants: It protects the oxidation of rubber. Example: Phenyl betanapthylamine and Para-hydroxydiphenyl.

Special ingredients: Paraffin wax produces a protective barrier to oxygen attack and water absorption. Resin increase tackiness.

Synthetic rubber:

Characteristics: In general they are: ----------

More resistant to high and less resistant to low temperatures.
More resistant to the agents that accelerate ageing e.g. Light, Oxidation & its catalyst, Copper and Manganese.
More difficult to process.
More expensive.

Types: The following four types of synthetic rubber are used as closure materials for parenteral products: -

Butyl rubber: These are co-polymers of isobutylene with 1% to 3% of isoprene or butadiene.

Nitrile rubber: These are butadiene-acrylonitrile co-polymers. It is highly oil resistances.

Chloroprene rubber: These are polymers of 1:4 chloroprenes. It is polar and highly resistant to oil. It is also resistance to oxidation.

Silicon rubber: They are made by polymerization of methyl silicon fluids. Nitrile groups are sometimes introduced to improve oil resistance. 


DIFFERENCE BETWEEN SINGLE-DOSE AND MULTI-DOSE CONTAINERS

Single-dose container
Multi-dose container

A single-dose container is a hermetically sealed container.
A multi-dose container is sealed in such a way that the rubber closures allow the withdrawl of doses by puncture with hypodermic needles.

It contains only one dose of the sterile drug.
It contains a number of doses of sterile drug.

The container is once opened it cannot be resealed with assurance that sterility has been maintained.
Because of using the rubber closures, successive portions of the contents can be withdrawn without changing the strength, quality or purity of the remaining portion.

Commonly single-dose injections are known as ampoules which are sealed by fusion of glass of the container under aseptic conditions.
Commonly multi-dose injections are known as vial which is a small glass container with non removable rubber top through which a needle is inserted to withdraw the solution. 

The volume is very small.
The volume should normally not exceed 30ml for vial.

In single-dose injection presence of preservatives must not necessary. 
Preservative is necessary in multi-dose injections.

In single-dose container there is no used in closures.
The closures used in multi-dose containers create many problems which must be taken care of before selecting the closure. The problems are: -----
Absorption of materials from the products.
Shedding of undesirable soluble or insoluble components to the preparation.
Sometimes the closures react with the products.

Here glass containers are usually used
Here both glass and plastic containers are used.

These types of containers are breakable.
These types of containers are unbreakable, light and disposable. 

Accurate dose measurement is done in single-dose containers.
 Wrong dose measurement is done in multi-dose containers.
DESCRIPTION:

HEPA (High efficiency particulate air) filters are composed of ----------------

Various fibers like glass fiber, ceramic materials.
A continuous sheet of filtration materials.
Pleated fiberglass paper as the filter medium.

The parallel pleats of this filter material increase the surface area of the filter and also increase the air flow through the filter. Within the structure of the filter, the filter material is sealed to an aluminium frame. At least one side of the filter is protected with a coated mild steel mesh. Efficient gaskets are used to ensure that air cannot leak part the filter material or past the filter unit when it is mounted in its trunking. HEPA filters exhibit:

A high flow rate.
High particulate holding capacity.
Low pressure drop across the filter.

MECHANISM OF ACTION:

For clean room, air exits from the filter face at a rate of about 0.45 m/s and have 99.997% efficiency at removing 0.3(m particles. The initial pressure difference across the depth of the filter is about 130 Pascal (Pa) and at the end the pressure will increase to about 490 Pa. To retain the operating efficiency of the filter, the fan forcing air through the filter must be able to maintain this pressure difference. HEPA filters remove various particles from the air by the following process: -------------------

Larger particles by inertial impaction.
Medium-sized particles by direct interception.
Small particles by Brownian diffusion.

The efficiency of removing particles is affected by the air velocity and the filter packing. Larger and smaller particles will be removed more efficiently.

EFFICIENCY:

HEPA filters are capable of removing 99.99% of particles down to 1(m at an average air velocity of 100 ft/min (0.54 m/sec). The US standard requires a HEPA filter to have an efficiency of not less than 99.97% to mono-size 0.3(m particles of dioctyl phthalate (DOP) smoke.  
Quality control:

Quality control is a part of quality assurance. Quality control refers to the process of striving to produce a perfect product by a series of measures requiring an organized effort by the entire company to prevent or eliminate errors at every stage in production. It concerns quality control of raw materials, finished products and packaging materials.  
In the preparation of parenteral products strict quality control test must be carried out throughout the entire process of the preparation of parenteral products to give ensure that the final product must meet the specific standards. For this purpose, raw materials must be subjected to quality and pyrogens test. Various test and assay must be carried out for finished products to ensure that they must meet the required specification. In addition to the usual chemical or biological test, the following test must be carried out on the finished products of parenteral preparations for their standardization: -------------- 

Sterility test
Clarity test

pyrogen test 
Leaker test



Sterility test:

These tests are performed on all lots of injections in their final containers. Hence samples may be taken at random to represent the entire lot of the preparation. According to the U.S.P. there are two basic method for sterility testing: -----------

Direct inoculation of test sample on culture media
Filtration technique.

Direct inoculation method:

In this method, an aliquot quantity of test samples are transferred into culture tubes containing Fluid Thioglucolate Medium (FTM) or Soybean-Casein Digest Medium (SCDM). Then the tubes plugged with sterilized cotton wool and incubated at 20-250C temperature for 7 to 14 days for SCDM or 30-350C temperature for 7 to 14 days for FTM.

At the same time, positive and negative control test are carried out under the same condition to confirm the sterility and growth promoting activities of the medium. The whole operation must be carried out under aseptic condition to prevent the accidental entry of microorganism into the test.

Results: If here is no growth of microorganism appears in the tubes, the test materials are considered to be sterile. But, there is any growth; the test must be repeated for 2nd time with fresh test sample and culture media because in the first time, the microbial growth may be due to accidental entry of microorganism. If the 2nd time also shows the growth it may be repeated 3rd time very carefully. If this time also growth appears, then the materials fail to pass the sterility test.
     
Filtration method:

In this method, the testing solution passed through the membrane filter having sufficiently small pore size to retain bacteria. Then the membrane is washed by isotonic salt solution to remove at least inhibitory properties. Then one half of the filter is transferred asceptically to appropriate culture media and incubated at 20-250C temperature for 7 days for SCDM and 30-350C temperature for 7 days for FTM.

At the same time, positive and negative control test are carried out under the same condition to confirm the sterility and growth promoting activities of the medium. The whole operation must be carried out under aseptic condition to prevent the accidental entry of microorganism into the test.

Results: If here is no growth of microorganism appears in the tubes, the test materials are considered to be sterile. But, there is any growth; the test must be repeated for 2nd time with fresh test sample and culture media because in the first time, the microbial growth may be due to accidental entry of microorganism. If the 2nd time also shows the growth it may be repeated 3rd time very carefully. If this time also growth appears, then the materials fail to pass the sterility test.

If the product has antimicrobial activity, they must be neutralized or eliminated by dilution. For solids or oily materials which make the culture medium turbid and make it difficult to conclude, whether the turbidity is due to microbial growth or due to materials itself, the normal test may have to be modified by sub-culturing the medium. If turbidity in sub-culture does not appear the materials is sterile but if turbidity appears due to microbial growth which shows that the material is not sterile.      

Pyrogen test:

Pyrogen: Pyrogens are the metabolic products of microorganism that are produced by all microorganism like Gram positive (+ve), Gram negative (-ve) bacteria and fungi. They are soluble, filterable, thermostable and non volatile substances polysaccharides or an amino acid carrier. When introduced in human beings they caused febrile reaction which includes: ------------

Chillis and fever with headache.
Pain in the back and legs.

At high dose levels it will also: -----------

Activated the coagulation system.
Alter carbohydrate and lipid metabolism.
Produce platelet aggregation.
Produce shock and ultimately death.

According to B.P. there are two types of test are available for pyrogen testing include: ---------------

Rabbit test
LAL test

Rabbit test:

Only healthy and mature rabbit should be used because they show similar physiological response to pyrogenic substances like that of man, but they are very sensitive to external stimuli. A suitable quantity of test samples (10ml/kg) is administered into the ear vein of the rabbit. Rectal temperatures are noted at 1, 2 and 3 hours after the introduction of the injection.

Results: If no rabbit shows the individual temperature rise in 0.60C or more above and if the sum of the three individual maximum temperature rise does not exceed 1.40C, the test sample meets the requirements for the absence of pyrogen.

If any rabbits show the individual temperature rise in 0.60C or more above and if the sum of the three individual maximum temperature rise exceeds 1.40C repeat the test using five another rabbits. If not more than 3 out of 8 rabbits show individual temperature rise in 0.60C or more and if the sum of the 8 individual maximum temperature rise does not exceeds 3.70C the test sample meets the requirements for the absence of pyrogen. 

LAL test:

This test commonly referred to as the limulus amoebocyte lysate (LAL) test. It is an in vitro test for bacterial endotoxin or pyrogens use a lysate of amoebocyte from the horseshoe crab Limulus polyphemus.

Procedures: In the test procedure, the lysate is mixed with an equal volume of test solution on a depyrogenate container. Then the container is incubated undestrubly at 370C for 60 minutes, the end point is identified by gently inverting the glass tube.
  
At the same time, positive and negative control test are performed under the same condition to confirm the sterility and sensitivity of the lysate. The whole operation must be carried out under asceptic condition to prevent the accidental entry of microorganism into the test.  

Results: A positive result is indicated by the formation of a solid clot, which does not disintegrate when the tube is inverted. A negative result is indicated if no gel clot has been formed. This test will detect between 0.02 – 1.0 endotoxin units/ml.
  
Advantages: Advantages of LAL test are as follows: ------------
It is cheap
It is rapid
It is simple
It is sensitive to low endotoxin concentrations. 

Precaution: Before the test is carried out it is necessary to determine that --------------
The test equipment does not adsorb endotoxin
The lysate is of suitable sensitivity
No interfering agents are presents. 
Leaker test:

Leaker lest is performed to detect the presence of passage (capillary pores or tiny cracks) for leaking of the content from the ampoule. In this test, unlabelled final ampoules are dipped into deeply colored dye solution usually 1% methylene blue (MB) solution. The whole process is carried out in a vacuum chamber under negative pressure. When the vacuum is released the colored solution will enter the ampoules through a defective sealing. After careful washing of ampoules from outside, the dye solution can be seen in the leaker ampoules. And those ampoules are rejected. Capillaries of about 15( in diameter can be detected by this test method.     
Disadvantages:

This test is not performed on vials and bottles because of flexibility of rubber closures.
Moreover the dye will badly stain the rubber stopper.

Clarity test:

Clarity test is performed to detect the presence of particulate matter in parenteral preparations. In this test, the unlabelled final containers are set up against strongly illuminated white surface for the detection of light colored particles. This test is done with naked eye. The containers are slowly inverted and rotated. If any particular matter is visible, the package is rejected. 

Sterilization:

Sterilization is the process by which all viable microorganisms including spores are killed or eliminated. OR The term “Sterilization” as applied to pharmaceutical preparations, means the complete destruction of all living organisms and their spores or their complete removal from the preparation. This is important in many fields, particularly in surgery and in microbiological works.

Five general methods are used for the sterilization of pharmaceutical products: -------------

Dry heat sterilization   
Moist heat sterilization

Sterilization by filtration
Gas sterilization

Sterilization by ionizing radiation




Dry heat sterilization:

Mechanism of action:

Dry heat treatments have two targets: (1) Microorganisms & (2) Their by-products. The aim of sterilization is to destroy the ability of microorganisms to survive and multiply. Depyrogenation seeks to destroy the chemical activity of the by-products, pyrogens or endotoxins (synonymous for the sake of simplicity).

Both processes consist of an oxidation that is almost combustion. However the temperatures required to achieve depyrogenation are distinctly higher than those needed to obtain sterilization. Example: Fixed oil, Glycerin. 

Advantages:

It can be used for substances that would be harmed by moisture. Example: Oily materials and Powders.
It is suitable for assembled equipment, provided sufficient time for penetration is allowed. Example: All glass syringes.
It is less damaging to glass and metal equipment than moist heat.
Some articles of porcelain can be sterilized by this method.

Disadvantages:

Most rubbers and plastics cannot be sterilized by this method because they perish.
The drastic conditions – high temperature, long exposure and very long heating up times make this method to unsuitable for thermolabile products.
It is unsuitable for surgical dressings.
It is a time consuming process and needs high temperature.

Moist heat sterilization:

Microorganisms can be exposed to moist heat by using hot water, boiling water, steam at atmospheric pressure (steaming) or steam under pressure (autoclaving). It can kill microorganisms at lower temperatures and in shorter time than dry heat. For example: All vegetative bacteria are destroyed at 1 hour at 800C and very few will survive 10 minutes at this temperature. The spores of Clostridium tetani are destroyed by 30 min. at 1150C.  

Mechanism of action:

Moist heat is believed to destroy microorganisms by causing protein coagulation or denaturation. When heat is applied in the presence of sufficient water, disulphide bonds and hydrogen bonds between the protein strands can be broken and the strands have sufficient mobility to form new linkages resulting in the denaturing of the protein, which if it is part of an enzyme will render it inactive.

Advantages:

It is suitable for surgical dressing.
Most medicaments, rubbers and plastics are sterilized by this method.
It can kill microorganisms at lower temperature and in shorter time.
PVC can be sterilized by this method.
The apparatus is inexpensive and simple.
Disadvantages:

It cannot be used for substances that would be harmed by moisture. Example: Oily materials and Powders.
It is more damaging to glass and metal equipment than dry heat.
It cannot be used for injections and articles, such as some plastics, that deteriorate at 1150C.
It is unsuitable for assembled equipment, due to sufficient time for penetration is allowed. Example: All glass syringes.

Sterilization by Filtration:

Filtration through a bacteria proof filter is a suitable method for sterilization of injections containing thermolabile medicaments. Generally thermolabile medicaments would suffer damage if subjected to heat sterilization. The process involves four stages: --

Filtration of the solution through a bacteria proof filter.
Aseptic distribution of the filtered solution into previously sterilized containers.
Aseptic closure of the containers.
Testing of sample for sterility.

Mechanism of action:

The filtration technique in sterilization flow the following mechanisms:

Straining: Here, the pores of the filters are smaller than bacteria or other foreign particles. Thus they easily retained when the solution are passed through the membrane filter. Example: Remove of bacteria & fiber from parenteral products.

Retention on pore irregularities: An organism passing along a pore in a sintered or fibrous filter travels a tortuous path that has a very uneven surface. It has been estimated that there are 2000 irregularities/cm of pore in an unglazed porcelain candle. Bacteria may be stopped by or trapped in these hazards.

Impingement: As a flowing fluid approaches a cylindrical object such as a fiber in the wave of a filter cloth. Suspended solids may have sufficient momentum to strike the fiber. If they do so they are retained but others may flow the steam lines and be trapped a little later. An accumulation of solids builds up on the fibers and eventually forms a cake over the surface.

Attractive force: Here, electrostatic and other surface forces may exert sufficient hold on the particles to attract and retained them.

Bridging and entanglement: When using a fibrous filter cloth or filter pad the particles may entangle with the fibers and form ridge over them. If there is insufficient solid to form a cake then all particles must be removed by this mechanism. There must be sufficient depth to the filter medium to ensure that they are eventually trapped with a high degree of probability.     



Advantages:

No heat is used, thus ideal for thermolabile solutions.
Removes all bacteria and fungi and often clarifies the solution.
Useful process for sterilization of large volume solution.
Useful for eye drops as dropper bottles do not withstand heating processes well.

Disadvantages:

Aseptic technique is required. Thus highly trained staff and sterile equipment and facilities are required.
Sterility tests are required. Except in emergency, issue is not permitted until tests have been passed.
Viruses, filterable forms of bacteria and bacterial products such as toxins and pyrogens are not removed or destroyed.
Filter may break down either suddenly or gradually in use.
Filtration unit may leak and permit entry of non sterile air.
Adsorption can occur with some filters. Example: candles and fibrous pads.
Clogging can occur with prolonged filtration.
Bacteria may grow through some types of filters with lengthy filtration runs.
Filtration cannot be used for sterilization suspensions.
Oxidation may occur on larger filters and the medicament must be stable in the solvent.

Clean area:

Clean area is a room with the environmental control of particulate and microbial contamination, constructed and used in such a way as to reduce the introduction, generation and retention of contaminants with the area.
 
Aseptic area:

Aseptic area is a room or special area within the clean area designed constructed serviced and used with the intension of preventing microbial contamination of the product.

Conventional flow:

Filtered air is pumped into the room to produce a positive pressure compared to the exterior and in a turbulent fashion of scavenge particles already present, flush them out  and so maintain clean condition. Conventional air flow is defined in term of the no. of air change per hour. According to B.P. standards ( 20 air change/hr. 
Unidirectional air flow:

Here the room is conventionally swept by a cushion of filtered air. Laminar flow is defined in terms of air velocity, parallel flow lines, may be either vertical or horizontal. Complete laminar air flow has little practical application in pharmaceutical product manufacturing.


Questions: How large volume of parenteral solution must be isotonic in comparison to blood plasma?

Answer:

Large volume of parenteral solutions must be isotonic in comparison to blood plasma. The reasons can be understood from the following discussion: ------------------

The parenteral solutions which have the same osmotic pressure of blood or 0.9% NaCl solution is termed as isotonic preparations.

A solution with an osmotic pressure greater than the blood plasma is called hypertonic solution and a solution with an osmotic pressure smaller than the blood plasma is called hypotonic solution. Now we can have an idea, actually what’s happened when hypertonic or hypotonic solutions are administered in the blood – by observe the following discussion: ---------------

Fragility shown by blood cells:

When hypotonic solution is given here the osmotic pressure, within the blood cell is larger than the hypotonic solution. Therefore, solvent particle enters the blood cell and make the cell bursts and irreversibly damage. 
Crenulation shown by blood cells:

When hypertonic solution are given, the osmotic pressure outside the blood cell is larger, therefore the liquid particles from the cell is extracted by the hypertonic solution by osmosis and cause shrinkage. This process is called crenulation of blood cell.

From the above discussion we can easily conclude that, hypertonic or hypotonic solution may hazard the red blood cell. Thus large volume of parenteral preparation must be isotonic.  

No comments:

Post a Comment